HMGB1 blockade attenuates experimental autoimmune myocarditis and suppresses Th17‐cell expansion

No abstract is available for this paper.

• Publication year

  2011

• Venue

  European Journal of Immunology

• Publication date

  2011-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/eji.201141879PMID 21928275
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Overexpression of human C-reactive protein exacerbates left ventricular remodeling in diabetic cardiomyopathy.

  2011cited by this paper
• Paradoxical function for the receptor for advanced glycation end products in mouse models of pulmonary fibrosis.

  2011cited by this paper
• IL-6-mediated Th17 differentiation through RORγt is essential for the initiation of experimental autoimmune myocarditis.

  2011cited by this paper
• High-mobility group box 1 promotes early acute allograft rejection by enhancing IL-6-dependent Th17 alloreactive response

  2011cited by this paper
• Serum levels of HMGB1, survivin, and VEGF in patients with advanced non-small cell lung cancer during chemotherapy.

  2010cited by this paper
• Targeting HMGB1 in inflammation.

  2010cited by this paper
• Is HMGB1 a New Indirect Marker for Revealing Fibrosis in Chronic Hepatitis and a New Therapeutic Target in Treatment?

  2010cited by this paper
• The rag locus of Porphyromonas gingivalis might arise from Bacteroides via horizontal gene transfer

  2010cited by this paper
• HMGB1 and RAGE in inflammation and cancer.

  2010cited by this paper
• Differentiation Imbalance of Th1/ Th17 in Peripheral Blood Mononuclear Cells Might Contribute to Pathogenesis of Hashimoto’s Thyroiditis

  2010cited by this paper
• CD69 Limits the Severity of Cardiomyopathy After Autoimmune Myocarditis

  2010cited by this paper
• HMGB1 Attenuates Anti-Metastatic Defense of the Lymph Nodes in Colorectal Cancer

  2010cited by this paper
• The transient nature of the Th17 phenotype

  2010cited by this paper
• Myocarditis: Infection Versus Autoimmunity

  2009cited by this paper
• HMGb1 promotes scratch wound closure of HaCaT keratinocytes via ERK1/2 activation

  2009cited by this paper
• CD24 and Siglec-10 Selectively Repress Tissue Damage–Induced Immune Responses

  2009cited by this paper
• Serum cathepsin K and cystatin C concentration in patients with advanced non-small-cell lung cancer during chemotherapy.

  2009cited by this paper
• IL-17 and Th17 Cells.

  2009cited by this paper
• The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation

  2009cited by this paper
• The Alarmin Cytokine, High Mobility Group Box 1, Is Produced by Viable Cardiomyocytes and Mediates the Lipopolysaccharide-Induced Myocardial Dysfunction via a TLR4/Phosphatidylinositol 3-Kinase γ Pathway

  2009cited by this paper
• CD11b+ Monocytes Abrogate Th17 CD4+ T Cell-Mediated Experimental Autoimmune Myocarditis1

  2008cited by this paper
• Effects of HMGB1 on ischemia-reperfusion injury in the rat heart.

  2008cited by this paper
• The role of cell death in the pathogenesis of autoimmune disease: HMGB1 and microparticles as intercellular mediators of inflammation

  2008cited by this paper
• Adenovirus‐mediated ICOSIg gene transfer alleviates cardiac remodeling in experimental autoimmune myocarditis

  2008cited by this paper
• Sensing danger—Hsp72 and HMGB1 as candidate signals

  2008cited by this paper
• HMGB1: Endogenous Danger Signaling

  2008cited by this paper
• CD4 T cells: fates, functions, and faults.

  2008cited by this paper
• Pathogenesis of myocarditis and dilated cardiomyopathy.

  2008cited by this paper
• A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell–mediated tissue damage

  2008cited by this paper
• A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA.

  2007cited by this paper
• Interleukin-17 in fashion, at last: ten years after its description, its cellular source has been identified.

  2007cited by this paper
• Clustal W and Clustal X version 2.0

  2007cited by this paper
• Cells migrating to sites of tissue damage in response to the danger signal HMGB1 require NF-κB activation

  2007cited by this paper
• Interleukin-17: a new paradigm in inflammation, autoimmunity, and therapy.

  2007cited by this paper
• A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell–mediated tissue damage

  2007cited by this paper
• IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system.

  2007cited by this paper
• Alteration of IL-17 related protein expressions in experimental autoimmune myocarditis and inhibition of IL-17 by IL-10-Ig fusion gene transfer.

  2007cited by this paper
• Role of HMGB1 in cardiovascular diseases.

  2006cited by this paper
• The cytokine activity of HMGB1

  2005cited by this paper
• Autoimmune heart failure: new understandings of pathogenesis.

  2005cited by this paper
• Release of High Mobility Group Box 1 by Dendritic Cells Controls T Cell Activation via the Receptor for Advanced Glycation End Products1

  2005cited by this paper
• HMGB1: guiding immunity from within.

  2005cited by this paper
• The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion

  2005cited by this paper
• Involvement of Toll-like Receptors 2 and 4 in Cellular Activation by High Mobility Group Box 1 Protein*

  2004cited by this paper
• Mini‐review: The nuclear protein HMGB1 as a proinflammatory mediator

  2004cited by this paper
• High Mobility Group Box Protein 1: An Endogenous Signal for Dendritic Cell Maturation and Th1 Polarization

  2004cited by this paper
• HMGB1 is an endogenous immune adjuvant released by necrotic cells

  2004cited by this paper
• Interleukin-6–Deficient Mice Resist Development of Autoimmune Myocarditis Associated With Impaired Upregulation of Complement C3

  2003cited by this paper
• Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion

  2003cited by this paper
• Modulation of chemokine receptor expression and chemotactic responsiveness during differentiation of human naive T cells into Th1 or Th2 cells

  2002cited by this paper
• High Mobility Group 1 Protein (Hmg-1) Stimulates Proinflammatory Cytokine Synthesis in Human Monocytes

  2000cited by this paper
• The Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin

  1995cited by this paper
• Myocarditis. A histopathologic definition and classification.

  1987cited by this paper
• Cardiac myosin induces myocarditis in genetically predisposed mice.

  1987cited by this paper
• Postinfectious Autoimmunity: Two Distinct Phases of Coxsackievirus B3‐Induced Myocarditis a

  1986cited by this paper

• NMI promotes the secretion of IL-17 and exacerbates psoriasis.

  2026cites this paper
• Macrophage immunometabolism dysregulation and inflammatory disorders.

  2025cites this paper
• Estrogen and Estrogen Receptors in Cardioimmunology: Implications in Physiology, Pathophysiology, and Therapeutic Strategies

  2025cites this paper
• HMGB1 regulates Th17 cell differentiation and function in patients with psoriasis

  2024cites this paper
• The Role of Alarmins in the Pathogenesis of Rheumatoid Arthritis, Osteoarthritis, and Psoriasis

  2024cites this paper
• Innate and adaptive immunity in acute myocarditis.

  2024cites this paper
• ET-1 receptor type B (ETBR) overexpression associated with ICAM-1 downregulation leads to inflammatory attenuation in experimental autoimmune myocarditis

  2023cites this paper
• Anti-high mobility group box protein 1 monoclonal antibody downregulating P-glycoprotein as novel epilepsy therapeutics

  2022cites this paper
• ADAM10 inhibits the interaction between IL-17 and HMGB1 in Buerger's disease.

  2021cites this paper
• Natural products with antiinflammatory activities against autoimmune myocarditis

  2021cites this paper
• Ethyl Pyruvate Ameliorates Experimental Autoimmune Myocarditis

  2021cites this paper
• Targeting HMGB1 in the Treatment of Non-Small Cell Lung Adenocarcinoma

  2021cites this paper
• B10 cells decrease fibrosis progression following cardiac injury partially by IL‐10 production and regulating hyaluronan secretion

  2021cites this paper
• Fibroblast transdifferentiation promotes conversion of M1 macrophages and replenishment of cardiac resident macrophages following cardiac injury in mice

  2020cites this paper
• Exacerbation of autoimmune myocarditis by an immune checkpoint inhibitor is dependent on its time of administration in mice.

  2020cites this paper
• Novel Therapeutic Effects of Pterosin B on Ang II-Induced Cardiomyocyte Hypertrophy

  2020cites this paper
• The Relationship between Extracellular/intracellular microRNAs and TLRs May Be Used as a Diagnostic and Therapeutic Approach in Sepsis

  2020cites this paper
• Inhibition of calpain alleviates coxsackievirus B3-induced myocarditis through suppressing the canonical NLRP3 inflammasome/caspase-1-mediated and noncanonical caspase-11-mediated pyroptosis pathways.

  2020cites this paper
• RAGE-induced ILC2 expansion in acute lung injury due to haemorrhagic shock

  2020cites this paper
• PPARα suppresses Th17 cell differentiation through IL-6/STAT3/RORγt pathway in experimental autoimmune myocarditis.

  2019cites this paper
• Ethyl Pyruvate Stimulates Regulatory T Cells and Ameliorates Type 1 Diabetes Development in Mice

  2019cites this paper
• Increased dermal expression of chromatin-associated protein HMGB1 and concomitant T-cell expression of the DNA RAGE in patients with psoriasis vulgaris

  2019cites this paper
• High Mobility Group Box-1 (HMGB1): A potential target in therapeutics.

  2019cites this paper
• HMGB1 as A Therapeutic Target in Autoimmune Diseases: The Journey So Far.

  2019influential citation
• PGE2 ameliorated viral myocarditis development and promoted IL-10-producing regulatory B cell expansion via MAPKs/AKT-AP1 axis or AhR signaling.

  2019cites this paper
• Dual faced HMGB1 plays multiple roles in cardiomyocyte senescence and cardiac inflammatory injury.

  2019cites this paper
• Glycyrrhizin administration ameliorates Streptococcus aureus‐induced acute lung injury

  2019cites this paper
• Reg3β from cardiomyocytes regulated macrophage migration, proliferation and functional skewing in experimental autoimmune myocarditis.

  2018cites this paper
• HMGB1 silencing in macrophages prevented their functional skewing and ameliorated EAM development: Nuclear HMGB1 may be a checkpoint molecule of macrophage reprogramming

  2018cites this paper
• Die Rolle des entzündungsassoziierten Gefahrensignals High Mobility Group Box 1 (HMGB1) in der Immunpathogenese der Psoriasis vulgaris

  2018cites this paper
• The Janus face of HMGB1 in heart disease: a necessary update

  2018cites this paper
• Angiotensin II enhances the acetylation and release of HMGB1 in RAW264.7 macrophage

  2018cites this paper
• The HMGB1 is increased in CSF of patients with an Anti‐NMDAR encephalitis

  2018cites this paper
• HMGB1 regulates T helper 2 and T helper17 cell differentiation both directly and indirectly in asthmatic mice

  2018cites this paper
• ANG II facilitated CD11+Ly6Chi cells reprogramming into M1‐like macrophage through Erk1/2 or p38‐Stat3 pathway and involved in EAM

  2018cites this paper
• Retraction Note to: Bio‑HMGB1 from breast cancer contributes to M‑MDSC differentiation from bone marrow progenitor cells and facilitates conversion of monocytes into MDSC‑like cells

  2017cites this paper
• Costimulation blockade by combining CTLA4Ig with anti-CD40L mAb markedly inhibits the inflammatory response of experimental autoimmune myocarditis

  2017cites this paper
• Targeting androgen receptor with ASC-J9 attenuates cardiac injury and dysfunction in experimental autoimmune myocarditis by reducing M1-like macrophage.

  2017cites this paper
• Angiotensin II–C–C chemokine receptor2/5 axis‐dependent monocyte/macrophage recruitment contributes to progression of experimental autoimmune myocarditis

  2017cites this paper
• Post-translational modifications of high mobility group box 1 and cancer.

  2017cites this paper
• Effects of subconjunctival administration of anti-high mobility group box 1 on dry eye in a mouse model of Sjӧgren’s syndrome

  2017cites this paper
• Up-regulation of TLR2 and TLR4 in high mobility group Box1-stimulated macrophages in pulpitis patients

  2017cites this paper
• Exploration of helminth-derived immunoregulatory molecules as options for therapeutic intervention in allograft rejection and autoimmune disease

  2016cites this paper
• Bio-HMGB1 from breast cancer contributes to M-MDSC differentiation from bone marrow progenitor cells and facilitates conversion of monocytes into MDSC-like cells

  2016cites this paper
• HMGB1 Facilitated Macrophage Reprogramming towards a Proinflammatory M1-like Phenotype in Experimental Autoimmune Myocarditis Development

  2016cites this paper
• Ethyl pyruvate attenuated coxsackievirus B3-induced acute viral myocarditis by suppression of HMGB1/RAGE/NF-ΚB pathway

  2016cites this paper
• Receptor for Advanced Glycation End Products (RAGE) in Type 1 Diabetes Pathogenesis

  2016cites this paper
• Involvement of high mobility group box 1 in the auto-inflammatory process in systemic lupus erythematosus

  2016cites this paper
• HMGB1Modulates the Treg/Th17 Ratio in Atherosclerotic Patients.

  2016cites this paper
• Emerging role of high mobility group box 1 in ANCA-associated vasculitis.

  2015cites this paper
• A study of classical and novel markers of disease in multiple sclerosis

  2015cites this paper
• High mobility group box-1 (hmgb1) in systemic vasculitides

  2015cites this paper
• High mobility group box-1 (hmgb1) in systemic vasculitides: The interplay with active disease, specific organ involvement and therapy

  2015cites this paper
• Immunopathogenesis of Myocarditis: The Interplay Between Cardiac Fibroblast Cells, Dendritic Cells, Macrophages and CD4+T Cells

  2015cites this paper
• Increased serum HMGB1 level may predict the fatal outcomes in patients with chronic heart failure.

  2015cites this paper
• HMGB1 silence could promote MCF-7 cell apoptosis and inhibit invasion and metastasis.

  2015cites this paper
• IFN-γ-producing Th17 cells bias by HMGB1-T-bet/RUNX3 axis might contribute to progression of coronary artery atherosclerosis.

  2015cites this paper
• Ethyl pyruvate ameliorates experimental colitis in mice by inhibiting the HMGB1-Th17 and Th1/Tc1 responses.

  2015cites this paper
• HMGB1 modulates Lewis cell autophagy and promotes cell survival via RAGE-HMGB1-Erk1/2 positive feedback during nutrient depletion.

  2015cites this paper
• Th17 cell expansion in gastric cancer may contribute to cancer development and metastasis

  2014cites this paper
• HMGB1 is an early and critical mediator in an animal model of uveitis induced by IRBP‐specific T cells

  2014cites this paper
• Experimental drugs for treatment of autoimmune myocarditis.

  2014cites this paper
• Blocking the receptor for advanced glycation end product activation attenuates autoimmune myocarditis.

  2014cites this paper
• Up-regulated HMGB1 in EAM directly led to collagen deposition by a PKCβ/Erk1/2-dependent pathway: cardiac fibroblast/myofibroblast might be another source of HMGB1

  2014influential citation
• HMGB1 in health and disease.

  2014cites this paper
• Anti-HMGB1 Neutralizing Antibody Ameliorates Neutrophilic Airway Inflammation by Suppressing Dendritic Cell-Mediated Th17 Polarization

  2014cites this paper
• Are urinary levels of high mobility group box 1 markers of active nephritis in anti‐neutrophil cytoplasmic antibody‐associated vasculitis?

  2014cites this paper
• Soluble receptor for advanced glycation end products alleviates nephritis in (NZB/NZW)F1 mice.

  2013cites this paper
• HMGB1: The Central Cytokine for All Lymphoid Cells

  2013cites this paper
• Inhibition of high-mobility group box 1 in lung reduced airway inflammation and remodeling in a mouse model of chronic asthma.

  2013cites this paper
• Advances in monoclonal antibody application in myocarditis

  2013cites this paper
• Anti‐high mobility group box 1 monoclonal antibody ameliorates experimental autoimmune encephalomyelitis

  2013cites this paper
• CD4+ T‐cell subsets in transplantation

  2013cites this paper
• IL-23–Independent Induction of IL-17 from γδT Cells and Innate Lymphoid Cells Promotes Experimental Intraocular Neovascularization

  2013cites this paper
• Cerebrospinal Fluid High-Mobility Group Box Protein 1 in Neuromyelitis Optica and Multiple Sclerosis

  2013cites this paper
• Increased HMGB1 serum levels and altered HMGB1 expression in patients with psoriasis vulgaris

  2013cites this paper
• A method of experimental rheumatoid arthritis induction using collagen type II isolated from chicken sternal cartilage.

  2013cites this paper
• Adult Onset Still's Disease and Autoinflammation

  2012cites this paper
• IL-17 contributes to cardiac fibrosis following experimental autoimmune myocarditis by a PKCβ/Erk1/2/NF-κB-dependent signaling pathway.

  2012cites this paper
• Update on coxsackievirus B3 myocarditis

  2012cites this paper
• HMGB1 Promotes the Differentiation of Th17 via Up‐Regulating TLR2 and IL‐23 of CD14+ Monocytes from Patients with Rheumatoid Arthritis

  2012cites this paper
• CSF high-mobility group box 1 is associated with intrathecal inflammation and astrocytic damage in neuromyelitis optica

  2012cites this paper
• Th17 Response and Inflammatory Autoimmune Diseases

  2011cites this paper
• Enhanced HMGB1 Expression May Contribute to Th17 Cells Activation in Rheumatoid Arthritis

  2011cites this paper
• Radiation combined with PD-1 inhibitor induces time-dependent changes in myocardial injury by regulating HMGB1-associated in�ammatory microenvironment

  year unknowncites this paper